Autophagy Modulation in MEK Inhibitor-Resistant Melanoma

British Journal of Dermatology - United Kingdom
doi 10.1111/bjd.17473
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Trametinib: A MEK Inhibitor for Management of Metastatic Melanoma

OncoTargets and Therapy
OncologyPharmacology
2015English

Why Do We Need a New BRAF-MEK Inhibitor Combination in Melanoma?

Oncology in Clinical Practice
Oncology
2019English

Noxa Upregulation by Oncogenic Activation of MEK/ERK Through CREB Promotes Autophagy in Human Melanoma Cells

Oncotarget
Oncology
2014English

Antitumor Activity of the Selective Pan-Raf Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma

Cancer Research
Cancer ResearchOncology
2013English

816 Autophagy Inhibition Sensitizes Targeted Therapy-Resistant Melanoma to MEK1/2 Inhibitors

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Antitumor Effects of the Investigational Selective MEK Inhibitor TAK733 Against Cutaneous and Uveal Melanoma Cell Lines

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2012English

Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma

Cancers
Cancer ResearchOncology
2019English

UBE2N Promotes Melanoma Growth via MEK/FRA1/SOX10 Signaling

Cancer Research
Cancer ResearchOncology
2018English

Shipping Out MEK Inhibitor Resistance With SHP2 Inhibitors

Cancer Discovery
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy